top of page
Women's Cancer Research Foundation - Ovarian Cancer

About Ovarian Cancer

Ovarian cancer can be difficult to detect early, making continued research essential. Scientists are working to better understand the disease, identify it sooner, and improve treatment options.

​

Explore the research and evidence helping shape the future of ovarian cancer care.

What is Ovarian Cancer?

Ovarian cancer is a group of diseases that can begin in the ovaries or related areas, including the fallopian tubes and the lining of the abdomen. It can be difficult to detect early, and in the United States it causes more deaths than any other gynecologic cancer. Continued research is essential to understanding these diseases, finding them sooner, and improving treatment.

 

Types of Ovarian Cancer

Ovarian cancers are classified in part by the cells where they begin. The type of cancer can affect how it behaves and which treatments may be recommended. Three main types are:

  • Epithelial ovarian cancer begins in cells that line the ovaries or fallopian tubes. This is the most common type.

  • Germ cell tumors begin in the cells that produce eggs.

  • Stromal cell tumors begin in the supporting tissue of the ovary, which includes cells that produce hormones.

 

Who Is at Risk?

Several factors may affect a person’s risk of developing ovarian cancer, particularly epithelial ovarian cancer:

  • Age: Risk increases with age. About half of women diagnosed with ovarian cancer are 63 or older.

  • Family history and inherited gene changes: A family history of ovarian, breast, or certain other cancers may be relevant. Inherited changes in genes such as BRCA1 and BRCA2, as well as Lynch syndrome, can increase risk.

  • Personal medical history: A history of breast, uterine, or colorectal cancer, or endometriosis, may be associated with increased risk.

  • Reproductive history: Never having given birth or having had difficulty becoming pregnant may be associated with increased risk.

  • Some forms of menopausal hormone therapy: Long-term use of estrogen without progesterone may increase risk.

 

Having one or more risk factors does not mean you will develop ovarian cancer, and many people who are diagnosed are not considered high risk. If you have concerns about your personal or family history, speak with your healthcare provider about your risk and whether genetic counseling may be appropriate.

 

There is currently no reliable screening test for ovarian cancer in people without symptoms. If you notice persistent changes that are unusual for you, discuss them with your healthcare provider. The following pages cover symptoms, risk reduction, screening, and treatment in more detail.

FORMERLY KNOWN AS THE NANCY YEARY WOMEN'S CANCER RESEARCH FOUNDATION
IN MEMORY OF NANCY AND BOB YEARY

ABOUT US 

Since 1985, the physicians and researchers at the WCRF have been at the forefront of pioneering clinical research, aimed at enhancing cure rates among women diagnosed with breast, ovarian, uterine, and cervical cancers. WCRF actively engages in designing, conducting, and disseminating groundbreaking research focused on cutting-edge medical treatments.


Furthermore, WCRF serves as a vital hub for both foundational and applied research, as well as education, pertaining to the latest advancements in the treatment of breast and gynecologic cancers. In addition to conducting and publishing original research, the WCRF, provides valuable clinical information to physicians and patients alike.
 

 

Subscribe to Our Newsletter

Thanks for submitting!

CONTACT 

T: 949-642-5165

F: 949-646-7157

​

​

699 Diamond Street
Laguna Beach, CA 92651

  • Womens Cancer Research Foundation on X
  • LinkedIn
  • Facebook
  • YouTube
  • Instagram
Wpmen's Cancer Research Foundation

© 2026 Women's Cancer Research Foundation All rights reserved.

Website design by Tribe of Digital Natives

bottom of page